Gastric bypass alters both glucose-dependent and glucose-independent regulation of islet hormone secretion

Obesity

Volumn 23, Issue 10, 2015, Pages 2046-2052

  Salehi, Marzieh ^a,b   Woods, Stephen C ^a   D'Alessio, David A ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON; GLUCOSE; INSULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOOD INTAKE; GLUCAGON BLOOD LEVEL; GLUCAGON RELEASE; GLUCOSE ABSORPTION; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; HEART RATE; HORMONE RESPONSE; HUMAN; HYPERINSULINEMIC HYPOGLYCEMIC CLAMP; HYPOGLYCEMIA; INSULIN RELEASE; INSULIN SENSITIVITY; MALE; PANCREAS ISLET BETA CELL; ROUX EN Y GASTRIC BYPASS; STOMACH BYPASS; ADVERSE EFFECTS; BLOOD; GASTRIC BYPASS SURGERY; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

GASTRIC BYPASS; GLUCOSE; HUMANS; INSULIN; INSULIN-SECRETING CELLS; MALE; MIDDLE AGED;

EID: 84942833078     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.21186     Document Type: Article

References (40)

1. Nguyen NT, Masoomi H, Magno CP, Nguyen XM, Laugenour K, Lane J., Trends in use of bariatric surgery, 2003-2008. J Am Coll Surg 2011; 213: 261-266.
2. Schauer PR, Kashyap SR, Wolski K, et al., Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 2012; 366: 1567-1576.
3. Mingrone G, Panunzi S, De Gaetano A, et al., Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 2012; 366: 1577-1585.
4. Camastra S, Muscelli E, Gastaldelli A, et al., Long-term effects of bariatric surgery on meal disposal and beta-cell function in diabetic and nondiabetic patients. Diabetes 2013; 62: 3709-3717.
5. Jorgensen NB, Jacobsen SH, Dirksen C, et al., Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance. Am J Physiol Endocrinol Metab 2012; 303: E122-E131.
6. Laferrere B, Heshka S, Wang K, et al., Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes. Diabetes Care 2007; 30: 1709-1716.
7. Salehi M, Prigeon RL, D'Alessio DA., Gastric bypass surgery enhances glucagon-like peptide 1-stimulated postprandial insulin secretion in humans. Diabetes 2011; 60: 2308-2314.
8. Salehi M, Gastaldelli A, D'Alessio DA., Altered islet function and insulin clearance cause hyperinsulinemia in gastric bypass patients with symptoms of postprandial hypoglycemia. J Clin Endocrinol Metab 2014; 99: 2008-2017.
9. Ludvik B, Nolan JJ, Roberts A, et al., A noninvasive method to measure splanchnic glucose uptake after oral glucose administration. J Clin Invest 1995; 95: 2232-2238.
10. Ludvik B, Nolan JJ, Roberts A, et al., Evidence for decreased splanchnic glucose uptake after oral glucose administration in non-insulin-dependent diabetes mellitus. J Clin Invest 1997; 100: 2354-2361.
11. Andersen DK, Elahi D, Brown JC, Tobin JD, Andres R., Oral glucose augmentation of insulin secretion. Interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels. J Clin Invest 1978; 62: 152-161.
12. Nauck MA, Heimesaat MM, Behle K, et al., Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers. J Clin Endocrinol Metab 2002; 87: 1239-1246.
13. Qualmann C, Nauck MA, Holst JJ, Orskov C, Creutzfeldt W., Insulinotropic actions of intravenous glucagon-like peptide-1 (GLP-1) [7-36 amide] in the fasting state in healthy subjects. Acta Diabetol 1995; 32: 13-16.
14. DeFronzo RA, Tobin JD, Andres R., Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237: E214-E223.
15. Salehi M, Gastaldelli A, D'Alessio DA., Blockade of glucagon-like peptide 1 receptor corrects postprandial hypoglycemia after gastric bypass. Gastroenterology 2014; 146: 669-680; e662.
16. Elahi D, Nagulesparan M, Hershcopf RJ, et al., Feedback inhibition of insulin secretion by insulin: relation to the hyperinsulinemia of obesity. N Engl J Med 1982; 306: 1196-1202.
17. Kim CH, Park JY, Shong YK, Hong SK, Kim GS, Lee KU., Suppression of endogenous insulin secretion by exogenous insulin in patients with insulinoma. Clin Endocrinol (Oxf) 2000; 52: 87-92.
18. Immonen H, Hannukainen JC, Iozzo P, et al., Effect of bariatric surgery on liver glucose metabolism in morbidly obese diabetic and non-diabetic patients. J Hepatol 2014; 60: 377-383.
19. Luzi L, Battezzati A, Perseghin G, et al., Lack of feedback inhibition of insulin secretion in denervated human pancreas. Diabetes 1992; 41: 1632-1639.
20. Boden G, Chen X, DeSantis R, Kolaczynski J, Morris M., Evidence that suppression of insulin secretion by insulin itself is neurally mediated. Metabolism 1993; 42: 786-789.
21. Lindgren O, Carr RD, Deacon CF, et al., Incretin hormone and insulin responses to oral versus intravenous lipid administration in humans. J Clin Endocrinol Metab 2011; 96: 2519-2524.
22. Claessens M, Calame W, Siemensma AD, van Baak MA, Saris WH., The effect of different protein hydrolysate/carbohydrate mixtures on postprandial glucagon and insulin responses in healthy subjects. Eur J Clin Nutr 2009; 63: 48-56.
23. Teff KL, Townsend RR., Early phase insulin infusion and muscarinic blockade in obese and lean subjects. Am J Physiol 1999; 277: R198-R208.
24. Ahren B., Autonomic regulation of islet hormone secretion-implications for health and disease. Diabetologia 2000; 43: 393-410.
25. Teff KL, Levin BE, Engelman K., Oral sensory stimulation in men: effects on insulin, C-peptide, and catecholamines. Am J Physiol 1993; 265: R1223-R1230.
26. D'Alessio DA, Kieffer TJ, Taborsky GJ Jr,., Havel PJ., Activation of the parasympathetic nervous system is necessary for normal meal-induced insulin secretion in rhesus macaques. J Clin Endocrinol Metab 2001; 86: 1253-1259.
27. Ahren B, Holst JJ., The cephalic insulin response to meal ingestion in humans is dependent on both cholinergic and noncholinergic mechanisms and is important for postprandial glycemia. Diabetes 2001; 50: 1030-1038.
28. Schwartz TW, Holst JJ, Fahrenkrug J, et al., Vagal, cholinergic regulation of pancreatic polypeptide secretion. J Clin Invest 1978; 61: 781-789.
29. Ertl AC, Mann S, Richardson A, et al., Effects of oral carbohydrate on autonomic nervous system counterregulatory responses during hyperinsulinemic hypoglycemia and euglycemia. Am J Physiol Endocrinol Metab 2008; 295: E618-E625.
30. Rossetti P, Porcellati F, Busciantella Ricci N, et al., Effect of oral amino acids on counterregulatory responses and cognitive function during insulin-induced hypoglycemia in nondiabetic and type 1 diabetic people. Diabetes 2008; 57: 1905-1917.
31. Adrian TE, Bloom SR, Bryant MG, Polak JM, Heitz P., Proceedings: radioimmunoassay of a new gut hormone-human pancreatic polypeptide. Gut 1976; 17: 393-394.
32. Vozarova de Courten B, Weyer C, Stefan N, et al., Parasympathetic blockade attenuates augmented pancreatic polypeptide but not insulin secretion in Pima Indians. Diabetes 2004; 53: 663-671.
33. Ionut V, Liberty IF, Hucking K, et al., Exogenously imposed postprandial-like rises in systemic glucose and GLP-1 do not produce an incretin effect, suggesting an indirect mechanism of GLP-1 action. Am J Physiol Endocrinol Metab 2006; 291: E779-E785.
34. Vahl TP, Tauchi M, Durler TS, et al., Glucagon-like peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats. Endocrinology 2007; 148: 4965-4973.
35. Falken Y, Hellstrom PM, Holst JJ, Naslund E., Changes in glucose homeostasis after Roux-en-Y gastric bypass surgery for obesity at day three, two months, and one year after surgery: role of gut peptides. J Clin Endocrinol Metab 2011; 96: 2227-2235.
36. Goldfine AB, Mun EC, Devine E, et al., Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal. J Clin Endocrinol Metab 2007; 92: 4678-4685.
37. Davis SN, Galassetti P, Wasserman DH, Tate D., Effects of antecedent hypoglycemia on subsequent counterregulatory responses to exercise. Diabetes 2000; 49: 73-81.
38. Diedrich L, Sandoval D, Davis SN., Hypoglycemia associated autonomic failure. Clin Auton Res 2002; 12: 358-365.
39. Greenbaum CJ, Havel PJ, Taborsky GJ Jr., Klaff LJ., Intra-islet insulin permits glucose to directly suppress pancreatic A cell function. J Clin Invest 1991; 88: 767-773.
40. Banarer S, McGregor VP, Cryer PE., Intraislet hyperinsulinemia prevents the glucagon response to hypoglycemia despite an intact autonomic response. Diabetes 2002; 51: 958-965.